Protocol for management of imported pediatric malaria decreases time to medication administration

David M Goldfarb1, Isabelle Gaboury, Natalie Dayneka

  • 1Division of Infectious Disease, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada. dgoldfarb@cheo.on.ca

Insights

Implementing a malaria management protocol in a pediatric hospital improved patient care. Children received better investigations and faster antimalarial treatment, reducing delays in care.

Area of Science:

  • Pediatric infectious diseases
  • Hospital quality improvement
  • Malaria treatment protocols

Background:

  • A malaria management protocol was established in a tertiary children's hospital in 1999.
  • A retrospective study evaluated malaria cases 10 years before and 7 years after protocol implementation.

Purpose of the Study:

  • To assess the impact of a malaria management protocol on patient care.
  • To evaluate changes in the time to appropriate antimalarial therapy.

Main Methods:

  • A before-and-after study design was used.
  • Retrospective chart review analyzed malaria admissions.
  • Key outcomes included time to treatment, mortality, hospital stay, and ICU admission.

Main Results:

  • Protocol implementation increased appropriate investigations for severe malaria (18% vs. 63%).
  • Time to antimalarial medication administration significantly decreased (8 hours vs. 5.5 hours).
  • More children received therapy before leaving the emergency department post-protocol.

Conclusions:

  • A pediatric malaria treatment protocol enhances diagnostic workups.
  • The protocol reduces the time to initiate appropriate antimalarial therapy.
  • Implementation leads to improved efficiency in malaria case management.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...